Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endothelium-derived relaxing factor (EDRF)].

N Toda1, T Okamura

  • 1Department of Pharmacology, Shiga University of Medical Sciences, Ohtsu, Japan.

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of vertebral left atrial size for staging of dogs with myxomatous valve disease.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
Same author

Measurement and comparison of individual external doses of high-school students living in Japan, France, Poland and Belarus-the 'D-shuttle' project.

Journal of radiological protection : official journal of the Society for Radiological Protection·2015
Same author

Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.

Veterinary journal (London, England : 1997)·2013
Same author

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.

British journal of cancer·2012
Same author

Large voltage-induced magnetic anisotropy change in a few atomic layers of iron.

Nature nanotechnology·2009
Same author

Endoscopic transpapillary approach to the gallbladder for diagnosing gallbladder cancer.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2007
Same journal

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Prediction of severe oral mucositis in cancer treatment: the role of the oral-gut axis in precision supportive care].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Iron dysregulation and ferroptosis in heart failure: the dual faces of deficiency and overload].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Pharmacological characteristics and clinical outcomes of Rimegepant (Nurtec<sup>®</sup> ODT), an oral CGRP receptor antagonist for the acute treatment and prevention of migraine].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Pharmacological properties and clinical trial results of datopotamab deruxtecan (Dato-DXd, Datroway<sup>®</sup>)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
Same journal

[Oxytocin regulates social familiarity-dependent mate choice in medaka].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026
See all related articles

Endothelium-derived relaxing factor (EDRF) is now widely accepted as nitric oxide (NO). This discovery highlights NO's crucial roles in regulating blood vessel function and nerve signaling, with implications for various diseases.

Area of Science:

  • Biochemistry
  • Physiology
  • Pharmacology

Background:

  • Endothelial cells release endothelium-derived relaxing factor (EDRF) upon stimulation.
  • EDRF's properties are similar to nitric oxide (NO), suggesting EDRF = NO.
  • NO is synthesized from L-arginine and activates soluble guanylate cyclase, increasing cyclic GMP.

Purpose of the Study:

  • To review the discovery and properties of EDRF.
  • To explore the identity of EDRF as nitric oxide (NO).
  • To discuss the emerging roles of NO in vascular and nerve function.

Main Methods:

  • Review of existing literature on EDRF and NO.
  • Analysis of chemical and functional properties of EDRF.
  • Evaluation of studies investigating NO's role in physiological and pathological processes.

Related Experiment Videos

Main Results:

  • EDRF is identified as nitric oxide (NO).
  • NO is produced by an enzyme acting on L-arginine.
  • NO modulates vascular tone and may function as a neurotransmitter.

Conclusions:

  • The identification of EDRF as NO has significant implications for understanding vascular and neural regulation.
  • Further research is needed to elucidate NO's roles in health and diseases like hypertension and diabetes.
  • NO's involvement in nerve function, inflammation, and immune responses warrants extensive investigation.